2020-05-14
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection (Nature Communications, (2020), 11, 1, (2251), 10.1038/s41467-020-16256-y)
Publication
Publication
Nature Communications , Volume 11 - Issue 1
The competing interests section of the original article contained an error. In the sentence “A patent application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom patent application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.
| Additional Metadata | |
|---|---|
| doi.org/10.1038/s41467-020-16452-w, hdl.handle.net/1765/127059 | |
| Nature Communications | |
| Organisation | Biophysical Genomics, Department Cell Biology & Genetics |
|
Wang, C. (Chunyan), Li, W. (Wentao), Drabek, D., Okba, N., van Haperen, R., Osterhaus, A., … Bosch, B. J. (2020). Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection (Nature Communications, (2020), 11, 1, (2251), 10.1038/s41467-020-16256-y). Nature Communications, 11(1). doi:10.1038/s41467-020-16452-w |
|
